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Abstract 
We present here a tutorial review on the electrospray mass spectrometry technique and its 
applications to the study of drug-nucleic acid noncovalent complexes. Particular emphasis has 
been made on the basic principles of the technique, to allow even the non-specialist to design fit-
for-purpose mass spectrometry experiments and interpret the results. Standard applications will 
be described in detail, including the determination of stoichiometries and equilibrium binding 
constants of noncovalent complexes, the study of binding kinetics, and the development of ligand 
screening assays. We also outline the potentials of more advanced and/or more recent MS-based 
techniques (tandem mass spectrometry, ion mobility spectrometry and gas-phase spectroscopy) 
for the study of the nucleic acid-ligand complexes.  




All mass spectrometers determine the mass-to-charge ratio of ions in vacuum, but there are 
various ways of ionizing molecules and transferring them from the solution to the mass 
spectrometer. Electrospray ionization [1; 2] is a commonly used ionization method for the 
analysis of biomolecules like peptides, proteins, and nucleic acids. The major feature of 
electrospray ionization mass spectrometry is that the analytes of interest can be transferred from 
the sample solution to the mass spectrometer with minimal fragmentation. Soon after the 
development of the first electrospray mass spectrometers, it was demonstrated that even 
noncovalent complexes could be detected intact [3]. This seminal paper in 1991 was the starting 
point of a whole field of research, namely the analysis of complexes of biological interest by ESI-
MS [4-6].  
The observation of intact DNA duplexes by ESI-MS was made in 1993 [7; 8], and the first 
reports on the observation of duplex-ligand interactions appeared soon thereafter [9; 10]. 
Electrospray mass spectrometry analysis of noncovalent complexes including for DNA or RNA-
targeting drugs has now found important applications as a screening tool in drug discovery [11-
15]. Two comprehensive reviews appeared in 2001, describing the analysis of various types of 
noncovalent DNA complexes (nucleic acid multi-stranded structures, nucleic acid-ligand 
complexes, and nucleic acid-protein complexes) by ESI-MS [16; 17]. Since then, the number of 
papers reporting ESI mass spectra of nucleic acid-ligand complexes has continued growing, and 
as the availability and ease of operation of ESI-MS mass spectrometers increases, the techniques 
is more and more commonly used among the panel of more traditional spectroscopic techniques.  
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2. The basics of electrospray ionization mass spectrometry (ESI-MS) 
2.1. Electrospray ionization (ESI)  
The electrospray mechanism 
In electrospray, the sample consists of an aqueous solution of the analyte. The sample is infused 
at atmospheric pressure with a syringe or from a liquid chromatograph. The electrospray 
mechanism has been described in several review papers [18-20], and a thorough description can 
be found in these references. Here we will just outline the major stages of the mechanism, which 
is generally divided in three steps: droplet formation, droplet fission and production of desolvated 
ions. The electrospray capillary containing the solution is maintained at a potential of a few 
kilovolt, and is located a few millimeters from the entrance of the mass spectrometer, which is 
generally at ground. The strong electric field causes an electrophoretic movement of the ions 
inside the liquid, and charged droplets are emitted at the tip of the capillary. The droplets are 
charged because they contain excess of ions of one polarity. The polarity of the droplet depends 
of the sign of the applied potential. For nucleic acids, negative ion mode is used because nucleic 
acids are naturally negatively charged in solution. 
The next step is droplet fission. As the droplets travel from the capillary to the mass 
spectrometer, they undergo collisions with the ambient gas, and the solvent evaporates. The 
radius of the droplets decreases at constant charge until the Coulomb repulsion between the 
charges becomes greater than the cohesive forces. At a critical radius called the Rayleigh limit, 
the droplets explode asymmetrically, producing a series of small daughter droplets from the 
surface of the mother droplet. The daughter droplets are therefore enriched with the ions that 
were at the surface of the mother droplet. The daughter droplets then undergo evaporation and 
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fission themselves. In about a hundred of microseconds, the size and charge of the droplets 
decreases to a point where single ions are isolated, surrounded by residual counterions and 
solvent molecules. The last step of the production of desolvated ions in the gas phase, and the 
most commonly accepted mechanism for large ions like the complexes described here is the 
"charge residue model": a final droplet with containing only one analyte ion (here a DNA ion or a 
noncovalent complex) evaporates until the last solvent molecule is lost.  
Electrospray of nucleic acids 
ESI-MS investigations of nucleic acids are carried out using negative ion polarity. This follows 
logically from the knowledge that the phosphodiester backbone of the DNA has a pKa < 1, and is 
therefore fully deprotonated in solution. In order to preserve native nucleic acid structures, 
solutions with an ionic strength corresponding to ~150 mM monovalent cation should be studied. 
However, a major limitation of electrospray mass spectrometry is its low salt tolerance, because 
of the counterion condensation on the nucleic acid during droplet evaporation. Even minute 
amounts of sodium or potassium result in the detection of a wide distribution of adduct 
stoichiometries on the DNA. Using ammonium acetate circumvents this salt adduct problem. In 
negative ion mode electrospray, the droplets carry excess negative charges consisting of DNA 
polyanions and acetate anions (Figure 1a). After complete solvent evaporation, further activation 
of the DNA with its ammonium cation counterions results in proton transfer reactions from NH4+ 
to PO–, hence neutralization of phosphates by protons. When using 150 mM ammonium acetate, 
only a small fraction of phosphates remain negatively charged (on average, 5 out of 22 in a 12-








Figure 1 (next page): Generic electrospray mass spectrometry experiment on drug-nucleic acid 
complexes. (a) Sample is prepared by mixing DNA (D; yellow) and ligand (L; green), and the 
sample is injected in the mass spectrometer via the electrospray source. The right side of the 
panel is a schematic view of the electrospray process at the molecular level in negative ion mode 
(see text for details). (b) Schematic representation of a hybrid quadrupole-time of flight mass 
spectrometer. The ion trajectory is in blue. The ions are produced in the electrospray source, and 
pass through different transfer optics where desolvation and focusing is completed. The 
quadrupole is used as transfer optics in simple MS mode or as a mass selective device for 
MS/MS experiments. The collision hexapole is used as transfer optics in simple MS mode or for 
collisional activation in MS/MS experiments. Finally ions are analysed according to their mass-
to-charge ratio using the time-of-flight analyzer and the number of ion of each m/z is counted on 
the detector. The differential pressures (from atmospheric pressure to high vacuum) inside the 
mass spectrometer are indicated. (c) Typical electrospray mass spectrum of a DNA-ligand 
mixture, showing three species of different masses m corresponding to the free DNA (D), 1:1 and 





Finally, even though most recent mass spectrometers allow recording ESI mass spectra from 
aqueous solutions in the negative ion mode, the signal is usually much enhanced when some 
methanol is added to the solution prior to injection. This is because methanol decreases the 
surface tension of the droplets and favors the droplet formation, fission, and evaporation 
processes. Usually 15-20% methanol is added to the samples just prior to infusion. This methanol 
concentration gives significant signal enhancement, minimizes risks of conformational changes in 
solution (as tested by circular dichroism spectroscopy), and was not found to induce major 
changes in the relative peaks intensities.  
2.2. Mass spectrometers (MS) [21] 
A legitimate question here is: which mass spectrometer to choose? The short answer is: any mass 
spectrometer can be used provided that it has an electrospray source! From home-made to 
sophisticated ultra-high resolution machines, all mass spectrometers can be tuned to observe 
nucleic acid-ligand complexes. The key is to choose instrumental settings that allow proper 
evaporation of the droplets and desolvation of the ions to obtain reasonably large ion signals, 
while minimizing extra internal energy uptake by the ions to avoid disruption of the noncovalent 
interactions between the nucleic acid and the ligand. Critical parameters are therefore source or 
capillary temperatures (kept as low as possible), and all acceleration voltages in the transfer 
optics (all cone, skimmer, and lens voltages along the ion path must be kept low) (Figure 1(b)).  
The resolution of the mass spectrometer will only influence the complexity of the mixtures that 
can be resolved in a single spectrum. It will also determine if the isotopic distribution of a given 
species can be resolved. Distinguishing the isotopic distribution can be very helpful to assign the 
charge of a peak (isotopes are separated by 1 Da, so on the m/z scale the spacing between isotopic 
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peaks is equal to the inverse of the charge: 1/z). Once the charge is known, the mass is obtained 
by multiplying the m/z of the peak by the charge. There are nevertheless other tricks to interpret 
mass spectra even if the isotopes are not resolved. Usually in nucleic acid-ligand investigations 
the masses of the nucleic acids and ligands mixed are known, and the easiest is to calculate the 
theoretical m/z for all possible complexes at different charges. 
The sensitivity determines how much sample is required to record the data. In any case, recording 
a single mass spectrum requires < 50 µL of sample at a nucleic acid concentration of 1-10 µM, 
hence less than a picomole of nucleic acid per spectrum. Figure 2 shows typical ESI mass spectra 
recorded on a Q-TOF Ultima Global mass spectrometer (Micromass, now Waters, Manchester, 
UK) from 30 µL of solution containing 5 µM of 12-mer duplex DNA d(CGCGAATTCGCG)2 
and 5 µM of ligand MMQ1 [22; 23]. The spectra are shown at two different "RF lens" voltages 
(the RF lens is accelerating the ions just after the ESI source). When using ammonium acetate 
solutions, a good indication of the softness of source conditions is the detection of a few 
remaining ammonium adducts on the nucleic acid anions [24]. The relative intensity of adducts 
decreases as the RF Lens1 voltage increases from 60 V to 100 V, but the relative intensities of 
free duplex vs. complexes does not change. However, if too high acceleration voltages are 
applied, dissociation of the duplex and/or the complexes can occur.  
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Figure 2: ESI mass spectra of a equimolar solution of d(CGCGAATTCGCG)2 duplex (molecular 
weight = 7292.86 Da) and MMQ1 (MW = 422.56 Da) collected at two different acceleration 
voltage (RFLens1). The desolvation is increased by using higher acceleration values. If too large 
voltage is applied, dissociation of the species will occur. 
 
2.3 Tandem mass spectrometry (MS/MS) and collision-induced dissociation 
(CID) 
In simple MS mode, all ions produced in the electrospray source travel to the analyzer and the 
instrumental parameters are chosen so as to keep fragmentation minimal. However, most mass 
spectrometers also offer the possibility to perform tandem mass spectrometry (MS/MS) 
experiments. A common MS/MS experiment consists in recording a product ion spectrum. In that 
case, ions of a given mass-to-charge ratio are isolated, fragmented, and the resulting fragments 
are analyzed. In a Q-TOF mass spectrometer (shown in Figure 1B), the ions are first selected in a 
quadrupole, and then accelerated into a hexapole filled with argon at low pressure. At each 
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collision of the ion with an argon atom, a fraction of the relative kinetic energy is converted to 
vibrational energy of the ion (also called internal energy). When the ions have accumulated 
enough internal energy they can fragment in the mass spectrometer. This process is called 
collision-induced dissociation (CID). The mass spectrum that is recorded after CID is the product 
ion spectrum. In the last part of the article, we will describe some applications of MS/MS in the 
field of nucleic acid-ligand studies. However, the most important information obtained on the 
composition of the solution is found in the source mass spectrum. 
3. Stoichiometry determination 
The major strength of mass spectrometry is its ability to resolve complex mixtures. As opposed to 
other spectroscopic techniques, mass spectrometry gives one signal for each species differing by 
mass. Therefore, the stoichiometry of each complex present in a given sample, even minor 
products, can be read directly from the mass spectrum.  From the mass of a complex, one can 
calculate the number of DNA strands involved, the number of bound cations if present, and the 
number of bound ligands.  
3.1. Detecting intact nucleic acid assemblies 
One of the first noncovalent complexes ever detected by ESI-MS was a DNA duplex. Now, 
several kinds of assemblies like duplexes, triplexes [25-27], and G-quadruplexes [27-35] have 
been successfully analyzed by ESI-MS. The key in sample preparation is to form the desired 
structure while minimizing the sodium and potassium contaminations. This is usually achieved 
by using ammonium acetate in replacement for NaCl or KCl. Similarly, pH adjustments are done 
with acetic acid or ammonia. Thermal denaturation and fluorescence ligand titrations in solution 
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have shown that duplex stability and ligand-duplex binding constants were very similar in 
NH4OAc and NaCl [36].  
The case of G-quadruplexes is a little more peculiar, because G-quadruplexes are stabilized by 
cations bound between the G-tetrads. Fortunately, most G-quadruplex forming sequences adopt a 
similar structure in the presence of ammonium ions as in the presence of potassium, with 
ammonium cations coordinated between tetrads. In the case of tetramolecular quadruplexes like 
[d(TGnT)]4, the inner ammonium cations are so tightly bound that they remain inside the G-
quadruplex even after complete evaporation of the solvent and of the outer counter-ions. This 
particularity of ESI-MS has been exploited to determine the number of ammonium ions 
embedded in parallel tetramolecular quadruplex structures. For the unmodified sequence 
[d(TGnT)]4, (n-1) ammonium ions are found in the quadruplexes, as shown in Figure 3 for 
[d(TG5T)]4. When one guanine is replaced by 7-deazaguanine (7G), the quadruplex  
[d(T7GGGGGT)]4 is detected with only three ammonium ions, suggesting that this modified 
tetrad do not forms a sufficiently stable architecture to keep the coordinated ammonium ion 
included between adjacent tetrads. The number of ammonium ions is therefore indicative of the 
number of effective tetrads present in the tetramolecular G-quadruplexes [34]. 
However, there are particular cases where the structure in potassium differs from the structure in 
ammonium. For example, the telomeric sequence GGGTTAGGGTTAGGGTTAGGG adopts a 
mostly parallel structure in potassium [37; 38], and an antiparallel structure in ammonium [33; 
35] (as in sodium). A remaining challenge is therefore to find experimental conditions that mimic 
the native structure while remaining compatible with ESI-MS. A recent paper describes an 
ethanol precipitation and washing procedure that allows detecting [d(TGnT)]4 with n-1 potassium 
cations inside [39]. This is showing the way towards resolving that challenge.  
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Figure 3: (A) Structure of guanine (G) and 7-deazaguanine (7G) derivative. (B) Structure of the 
guanine tetrad and the hypothetical 7-deazaguanine tetrad. (C-D) Zooms of the ESI mass spectra 
of the quadruplexes (C) [d(TGGGGGT)]4 with predominantly 4 ammonium ions bound, and (D) 
[d(T7GGGGGT)]4 with predominantly 3 ammonium ions bound. The quadruplex concentration 
was 5 µM. Spectra were recorded in 150 mM ammonium acetate, in negative ion mode on a Q-
TOF Ultima Global mass spectrometer. 
 
3.2. Stoichiometry of nucleic acid-ligand complexes 
Since 1994, results on intercalator and minor groove binders suggested that ESI-MS could be an 
effective analytical technique for the detection of specific noncovalent drug-DNA complexes and 
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that the stoichiometries of the complex observed in ESI-MS reflect the solution [9; 10; 40-43]. 
Our group also made several test experiments on drug-DNA systems where no binding is 
expected, and indeed no binding is detected using ESI-MS [43], but most of these (non)results 
are of course unpublished. This is however a convincing indication that the complexes detected 
by ESI-MS are indeed representative of the species present in solution (no false positive). 
Figure 4 shows the relative intensities of the different species detected by ESI-MS for solutions 
of different concentration of drugs DAPI, Hoechst 33342 and distamycin A (from 0 to 10 or 20 
µM), added to the 5 µM duplex (GGGGATATGGGG•CCCCATATCCCC)2 solution. For DAPI 
and Hoechst 33342, a small amount of 2:1 complex is detected, only once the AATT binding site 
is saturated. For distamycin A, the 2:1 complex becomes rapidly predominant as the drug 
concentration increases. This illustrates the utility of ESI-MS for stoichiometry characterization: 
binding cooperativity is detected unambiguously, and the contribution of minor species can also 
be detected (like the low abundance 2:1 complex in Figures 4A and 4B). 
 
Figure 4: Graphics representing the relative abundances of the different species as a function of 
the drug molar fraction added to a 10 mM duplex solution for (a) DAPI, (b) Hoechst 33342, (c) 
Distamycin A. (●) Abundance of the duplex; (▼) abundance of the 1 : 1 complex; (■) abundance 
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of the 2 : 1 complex. The lines have been added only to guide the eye. Spectra were recorded 
using a LCQ mass spectrometer. 
4. Quantitative aspects 
The position of the peaks in the ESI-mass spectrum allows determination of the stoichiometries 
of the complexes that are present in a sample.  In addition, the relative intensities of the peaks can 
be used to quantify the complexes. This section explains how to determine the concentration of 
each complex, perform binding assays, determine equilibrium binding constants, and monitor 
reaction kinetics using electrospray mass spectrometry. 
4.1. Determination of the concentrations from the relative intensities of mass 
spectral peaks 
Data processing allows the determination of the peak areas of the free DNA and each complex 
formed. The relative concentrations of free nucleic acid (D) and each complex (DL, DL2, DL3,…) 
are then calculated from the total nucleic acid concentration ([D]total) and the peak areas (A) using 
the following equations: 
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The total concentration of bound ligand is then calculated from the concentration of each 
complex (Equation 5), and the concentration of free ligand is equal to the total ligand 
concentration minus the concentration of bound ligand (Equation 6): 
[L]bound = [DL] + 2 × [DL2] + 3 × [DL3]       (5) 
[L]free = [L]total – [L]bound         (6) 
4.2. Binding assays 
To visually determine the relative affinity of a given ligand for different DNA structures, and 
therefore determine the ligand’s specificity, a convenient procedure is the graphical comparison 
of the amount of bound ligand (determined using Eq. 5), or of the complex/duplex ratio [44]. 
Figure 5 shows such graphical comparison obtained for the screening of cryptolepine [45] 
binding to three duplex DNA with different GC percentage, a triple helical DNA, and several G-
quadruplexes. ESI-MS results show that cryptolepine has the highest affinity for triplex DNA, in 
agreement with equilibrium dialysis experiments [45]. One advantage of ESI-MS over 
equilibrium dialysis is the very good reproducibility of the results and the rapidity of the 
experiments (less than 5 minutes per oligonucleotide target). A disadvantage is, as discussed 
above, the restrictions in the composition of the buffer. 
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Figure 5: ESI-MS binding assay. Concentration of bound ligand deduced from the ESI mass 
spectra of mixtures of 10 µM cryptolepine and different oligonucleotide structures: the 
antiparallel quadruplex [d(GGGGTTTTGGGG)]2, the human telomeric intramolecular 
quadruplex d(GGGTTA)3GGG, the parallel tetramolecular quadruplex [d(TG4T)]4, three self-
complementary duplexes and a triplex sequence  
d(CCTTTTCTCTTTCC)•d(GGAAAGAGAAAAGG)•d(CCTTTCTCTTTTCC). Each DNA 
assembly was tested at a concentration of 5 μM. ESI-MS spectra were recorded using the Q-Tof 
Ultima Global.  
 
In the experiments reported above, one nucleic acid-ligand mixture is tested at a time. However, 
provided that mass spectral peaks do not overlap, competition experiments using mixtures of 
several drugs for the same nucleic acids target [42; 46; 47] or even for several oligonucleotides at 
the same time can be performed [47-49]. In the latter case, very careful sodium or potassium 
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elimination must be achieved and high resolution mass spectrometers help reducing potential 
peak overlaps. 
4.3. Determination of equilibrium binding constants 
4.3.1. Equations 
The concentrations of all species at equilibrium allow the calculation of the equilibrium binding 
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×  = K1 × K2 × K3        (11) 
The order of magnitude of binding constants that can be determined using ESI-MS depends on 
the limit of quantification of the mass spectrometer (concentration of species giving a signal-to-
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noise ratio ≥ 10). K1 association constants from 103 M-1 [24] to 108 M-1 [36] have been 
determined using ESI-MS. 
4.3.2. Interpretation of the data: site equivalence or cooperative ligand binding 
Because the mass analyzer is sensitive to the total mass of the complex but not to the nature of 
the binding site, the binding constants calculated as described above are not equal to the 
microscopic equilibrium constants at each binding site. However they are mathematically related, 
as shown below in the simple example of the formation of a 2:1 complex. The microscopic 
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Taking into account that the total amount of DL measured in the mass spectrum is the sum of 
all complexes containing one ligand per DNA target, whatever the binding site (Eq. 16), the 
constants defined in Eq. (7-8) can be related to the microscopic constants defined in Eq. (12-15), 
as shown in Equations (17-18).  
[DL] = [DLa] + [DLb]          (16) 






1 +=           (18) 
If the two ligand binding sites are equivalent and independent, i.e. if KI = KII = KIII = KIV, then K1 
= 4 × K2. So a four-fold ratio between the constants K1 and K2 strongly suggests independent 
binding sites. If the ligand binding sites are not equivalent (KI ≠ KII and KIII ≠ KIV) or if they 
cooperative negatively (KIII < KII and KIV < KI), then K1 > 4 × K2. On the contrary, if the ligands 
bind with positive cooperativity (KIII > KII and KIV > KI), then K1 < 4 × K2.  
A consequence of the equations above is that the DNA targets used in the ESI-MS screenings 
must bear a limited number of binding sites in order to be able to interpret the ESI-MS binding 
constants in terms of binding mechanism or binding sites. Another reason for using 
oligonucleotides rather than long DNA is the higher sensitivity of the ESI mass spectrometers for 
smaller molecules. Note however that very large DNA strands can in principle be analyzed using 
ESI-MS [50-52]. 
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4.3.3. How reliable are equilibrium constants determined by ESI-MS? 
The binding constants are determined from a single mass spectrum. It does not require any 
titration. However, it is highly recommended to verify the binding constants by repeating the 
measurement with at least one different concentration of ligand. When the DNA and ligand 
concentrations are carefully determined, equilibrium binding constants are the same whatever the 
ligand concentration. A single mass spectrum is actually a sum of several scans, to obtain good 
statistics on the peak intensities. To give a feeling of the scan-to-scan variability and of the time 
required to record an exploitable mass spectrum, we calculated the equilibrium association 
constant for each 1-second scan, during the recording of the ESI mass spectrum from a sample 
containing 4 µM duplex d(CGCGAATTCGCG)2 and 4 µM netropsin ligand. The standard 
deviation of the binding constant value does not exceed 3.7 % of the mean value. 
 
Figure 6: Scan to scan evolution of the MS-determined equilibrium association constant K1 for 
an equimolar solution (4 µM) of netropsin drug and the dodecamer (CGCGAATTCGCG)2 (only 
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a 1:1 complex is observed). The green line shows the mean value. The red lines show the 95% 
confidence interval.  
 
All equations described above are based on the assumption that the intensity ratios determined in 
the ESI mass spectra are equal to the concentration ratios in solution. It is therefore assumed that 
free and complexed nucleic acid ions have the same response factors. What is the validity of this 
assumption?  
Response factors are affected by all parameters affecting ionization efficiency, transmission 
efficiency, and detection efficiency in the mass spectrometer. Parameters like the mass 
spectrometer's transmission and detection efficiencies depend on the instrument, not on the 
system under study. Usually, species with similar m/z transmit equally well, and species with the 
same charge z are detected with the same efficiency. When investigating complexes between 
nucleic acids and small molecules, the peaks of the free nucleic acid and its complexes at a given 
charge state are therefore not subjected to large differential response due to the mass 
spectrometer. However, when comparing assemblies of different size, like single strand and 
duplex, the relative intensities in the mass spectra are most probably not proportional to the 
relative abundances. 
Another factor playing a role when analyzing noncovalent complexes is the possible disruption of 
complexes on their way from the source to the mass analyzer (several µs). If the complex is more 
fragile than the free nucleic acid (this is the case for loosely bound ligands), then the binding 
constants would be underestimated (the complex is partially dissociated). If however the free 
nucleic acid is more fragile than the complex (this can happen for example when the nucleic acid 
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is itself a noncovalent complex like a triplex DNA), then the binding constants would be 
overestimated (the free DNA is partially dissociate). It is usually good practice to determine the 
binding constants by using different source parameters to determine how collisional activation in 
the source influences the relative intensities. In any case, the binding constants recorded at low 
voltages (soft condition) should always be preferred. 
The most unpredictable factor is however the electrospray response factor, i.e. the efficiency of 
production of the ions from the species in the charged droplets. In the ideal situation, all species 
used for quantification would have the same the ionization efficiency. Mechanistic studies of the 
electrospray process established that the electrospray response depends mainly on the analyte 
partitioning between the core of the droplet and its surface [53]. More hydrophobic analytes tend 
to move to the droplet surface while hydrophilic analytes tend to stay in the bulk of the droplet 
[54; 55]. When analyte concentrations are low compared to the amount of charges on the droplet 
surface (i.e. when using low analyte concentrations and low flow rates), all analytes can 
efficiently compete with the droplet surface and can become ionized, and there is no marked 
difference of response factors between analytes [56; 57]. However, when analyte concentrations 
are higher compared to the available charges on the surface, competition for ionization is biased 
towards the most hydrophobic analytes.  
What is meant by "low analyte concentration and low flow rate"? Flow rates down to a few 
nL/min can be attained with nanoelectrospray emitters [58], but these thin needle can not be used 
at physiological ionic strength (150 mM salt) because they clog rapidly. ESI-MS measurements 
are therefore typically done with conventional electrospray sources, with a syringe pump and 
assisting gas flow, at flow rates from 150 nL/min [59] to a few µL/min. In our experience, when 
performing ESI-MS determination of equilibrium binding constants at 4 µL/min injection flow 
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rates from solutions containing maximum 10 µM nucleic acid, with duplex minor groove 
binders, good agreement is obtained between ESI-MS binding constants and those determined by 
other methods [36], with a two-fold difference in response factor between free duplex and 
[duplex + minor groove binder] complex [60]. The case of minor groove binders is supposed to 
be particularly favorable because only slight distortion of the duplex DNA is associated with 
ligand binding, and hence only slight changes in hydrophilicity is anticipated. In contrast, studies 
of ligand bound to RNA aptamers that undergo conformational rearrangement upon binding 
showed significant discrepancies between abundances in ESI-MS and binding constants in 
solution [61].  
Another intriguing question is: with positively charged ligands, why do free DNA and complexed 
DNA nevertheless appear with the same total charge? Actually the reason for that is not clear, 
and would warrant further fundamental studies, but the experimental facts are that the charge 
state or distribution of charge states observed in ESI-MS depends more on the total size of the 
complex than on the spatial distribution of charges within a complex. When a slight shift of the 
charge state distribution is observed for the complexes with some ligands, as it is impossible to 
know at which charge state the relative intensities most closely mirror the relative abundances in 
solution, good practice would be to determine the binding constant separately for each charge 
state, and then calculate the average binding constant and the error inherent to the method. For 
example, from 60 binding constants determined for MMQ ligands (see companion paper 
[Monchaud et al]) and several duplexes and quadruplexes, the average standard deviation on 
log(K1) is equal to 0.2 (with average log(K1) = 5.0). 
In conclusion, even if the absolute values of binding constants might be taken with caution for 
the reasons outlined above, the error inherent to the ESI-MS method remains modest compared to 
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the selectivities that are expected for specific ligands. Furthermore, the relative affinities 
determined by ESI-MS usually match closely the ranking obtained by other methods [45; 62-64], 
thereby validating ESI-MS as an approach for screening a series of ligands for a given target or 
for determining ligand selectivity for various targets. As the main advantage of ESI-MS is its 
rapidity (2 min per spectrum is enough to obtain binding constants!), and the absence of false 
positives, it is a very attractive method for finding hits that are worth further more labor-intensive 
investigation by more traditional methods. 
4.4. Monitoring reaction kinetics using ESI-MS 
The use of ESI-MS to characterize ligand binding to DNA is not limited to the characterization of 
the equilibrium state. As only a few seconds of acquisition are necessary to obtain good statistics 
on the ion signals, ESI-MS can therefore be used to study slow kinetics (reactions occurring on a 
time scale of minutes to hours), by monitoring the relative intensities of the different peaks as a 
function of time. In the following example, ESI-MS was used to study the kinetics of 
hybridization of the human telomeric sequence by its complementary strand [65], mimicking the 
binding to the RNA template of telomerase, and to test the influence of a ligand (telomestatin) on 
this reaction kinetics. The telomeric G-rich strand d(GGGTTA)3GGG is folded into a G-
quadruplex in the experimental condition (50 mM NH4Ac pH 6.5). Mixing of the quadruplex 
with the complementary strand d(CCCAAT)3CCC sets the starting time of duplex formation, and 
the disappearance of the free G-quadruplex and appearance of the duplex are monitored by ESI-
MS, as shown in Figure 7. 
Traditional spectroscopic methods (UV spectrophotometry, circular dichroism or fluorescence 
resonance energy transfer) also allow studying the reaction kinetics of nucleic acids 
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hybridization, but they are not able to sort out the contribution of all different complexes on 
the kinetics pathway. ESI-MS has the great advantage of monitoring each species separately, 
which is of prime importance for study of the effect of drug binding on the reaction kinetics. 
When telomestatin is added to the G-quadruplex before addition of the complementary strand, 
1:1 and 2:1 complexes between telomestatin and the G-quadruplex can be distinguished. 
Furthermore, ESI-MS demonstrates that telomestatin is binding neither to the C-rich strand, nor 
to the duplex. The ESI-MS kinetic data therefore not only provide information on the reaction 
kinetics, but also on the reaction mechanism.  
 
Figure 7 (next page): (a) Schematic representation of the different equilibrium present in 
solution between the G-rich DNA strand, the drug Telomestatin, the C-rich DNA strand. (b) ESI 
mass spectra of a mixture of 5 µM d(GGGTTA)3GGG (“G”) and 5 µM d(CCCAAT)3CCC (“i”) 
after 200 s (top) and 2000 s (bottom). (B) ESI mass spectra of a mixture of 5 µM “G”, 5µM 
telomestatin, and 5 µM “i” after 200 s (top) and 2000 s (bottom). “Duplex” stands for “G·i”; 
“1:1” stands for “telomestatin·G”; “2:1” stands for “2 telomestatin·G”. The G strand and the 
complex telomestatin.G are colored in green. The resulting duplex is colored in red. (c) Relative 
abundances of the different forms of the G-strand as a function of time. The complementary 
strand (5 µM) is added to a solution (5 µM) of preformed (GGGTTA)3GGG quadruplex alone 
(left) or in the presence of 5 mM telomestatin (right). ● duplex; ● free G-strand; ▲1 : 1 complex 





5. Energetics: probing intermolecular interactions without solvent 
We briefly outlined in section 2 the principle of tandem mass spectrometry experiments. MS/MS 
experiments are performed on the nucleic-acid ligand complexes, so they probe the charged 
complexes isolated in the vacuum of the mass spectrometer, in complete absence of solvent. 
Although these experiments do not seem relevant to solution-phase studies, they can provide 
information that is difficult to determine from solution data [66-68]: the contribution of 
intermolecular interactions to ligand binding, free of any solvent contribution. Mass spectrometry 
is the only experimental technique that allows probing experimentally the intermolecular 
interactions in the gas phase.  
MS/MS experimental data are useful when compared to molecular modeling of the complexes in 
vacuo to ascertain which structural model fits the experimental data [24; 69]. With minor groove 
binding [43; 70] and intercalating complexes [43] with double-stranded DNA, we consistently 
found that MS/MS data were reliable with the structure of the complexes in solution being 
preserved in the gas phase ions. MS/MS data are also useful when compared to the solution-
phase binding constants to detect significant solvent contribution to the ligand selectivity. What is 
generally found is that, even though the main contribution to the binding free energy in solution 
may come from hydrophobic interactions, what usually fine tunes ligand selectivity among a 
given ligand family is short-range electrostatic contributions, and these small differences can be 
probed very sensitively by MS/MS. 
For those interested in learning more on the theoretical aspects of MS/MS, and how energetic 
information can be extracted from tandem mass spectrometry data, the following tutorial reviews 
are recommended: [71-73]. We also recently reviewed the do's and don'ts of using CID MS/MS 
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to obtain meaningful information on ligand-duplex complexes [43]. The main guidelines can 
be summarized as follows. When interpreting MS/MS data, it is important to know that the extent 
of fragmentation must be interpreted in terms of reaction kinetics (as opposed to an equilibrium 
in the gas phase): the fragmentation extent depends the amount of internal energy given to the 
parent ion by collisions, and on the time scale left for the parent ion to fragment before the 
product ion spectrum is recorded. The dissociation kinetics depends on an activation enthalpy 
term and an activation entropy term. Comparing activation enthalpies is what we are interested 
in, because this parameter is proportional to the interaction energy between the partners that 
dissociate.  
In order for the relative fragmentation extent of a series of complexes to reflect the relative 
interaction energies in the gas phase, all the following parameters must be kept as constant as 
possible throughout the comparisons [43]: (1) The amount of internal energy. This value is 
difficult to calculate, but the theory says that ions of similar mass and charge that are given the 
same collision energy will have the same internal energy. (2) The fragmentation time scale, 
which can change from instrument to instrument. This explains why the product ion spectra of a 
very same complex can be very different when recorded on different instruments [74]. Product 
ion spectra can be meaningfully compared only on a given instrument. (3) Finally, the 
dissociation rate is proportional to the activation enthalpy only if the activation entropies are the 
same. This means that all complexes compared must dissociate via the same pathway. We also 
have demonstrated that the only pathway that can provide direct information on the energetics of 
drug-nucleic acid intermolecular interactions is the loss of neutral drug from the negatively 
charged DNA [43; 69].  
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However, charged molecules represent an important class of compounds, and ligands with the 
strongest affinities for the negatively charged nucleic acids are generally positively charged in 
solution. If the positive charges come from protonation, proton transfer(s) from the ligand to the 
nucleic acid can result in the ligand coming off as a neutral. If the ligand cannot lose its positive 
charge and remains attached to the negatively charged nucleic acid, then no information on the 
ligand binding energetics can be obtained, but information on the ligand binding site becomes 
accessible, as described in section 6.1.  
6. Structural characterization of nucleic acid complexes using mass 
spectrometry-based strategies 
Often, comparative ESI-MS experiments on different nucleic acid sequences and different ligand 
concentrations allow making deductions on the possible binding sites just from the 
stoichiometries (section 3.2) and the binding constants (section 4.3.2) , but strictly speaking, the 
mass of a complex tells nothing about its tridimensional structure. There are nevertheless a 
variety of creative strategies to probe the structure of noncovalent complexes using mass 
spectrometers, and this is a very active field of research in the mass spectrometry community. 
Some of these strategies are briefly outlined below. 
6.1. MS/MS  
Loss of neutral drug is however not the only fragmentation pathway possible. When the ligand is 
positively charged and does not undergo proton transfer to the nucleic acid, the ligand remains 
attached to the negatively charged nucleic acid by Coulomb interactions (ion-ion interactions are 
very much stabilized in the gas phase because the dielectric constant of vacuum is by definition 
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equal to 1). Other instances where the ligand can remain attached to the nucleic acid is if the 
covalently reacts at the binding site [75; 76]. In those cases, cleavage of the nucleic acid 
backbone can become the preferred pathway in MS/MS, and the ligand binding site can be 
determined from the product ion spectrum like if the ligand was a covalent modification of the 
nucleic acid. This kind of behavior has been observed in RNA complexes with the 
aminoglycoside neomycin B [77], and the dissociation of duplex DNA/netropsin complexes [78].  
A trick may consist in making the oligonucleotide covalent bonds even weaker. For example, 
Three adenosine residues were mutated into deoxyadenosine in 16S ribosomal RNA [79]. 
Fragmentation occurs preferentially at these fragile sites, and upon ligand binding in the vicinity, 
a decrease in fragmentation efficiency was observed, indirectly indicating ligand binding. Finally, 
let us mention that there are other fragmentation methods than collision-induced dissociation that 
are believed to keep noncovalent interactions intact while fragmenting the DNA backbone. These 
methods include electron detachment dissociation (EDD) [80] and electron photodetachment 
dissociation (EPD) [81], but the applicability of these methods remains to be firmly established. 
Finally, another indirect way to determine ligand binding site by MS/MS is to use covalent 
chemical probes of the nucleic acid structure in solution, and use MS/MS to determine the 
location of these probes. In that case, MS/MS needs not be performed on the intact complex, but 
only on the labeled nucleic acid. Examples can be found in a recent study by Mazzitelli and 
Brodbelt [82], who used KMnO4 oxidation of thymines to probe thymine accessibility in DNA 
duplexes and their complexes with ligands, and in papers by Fabris and co-workers who 
investigated RNA structures and RNA-protein complexes [83-86].  
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6.2. Ion mobility spectrometry 
The strategies outlined above can be implemented in commercial mass spectrometers with 
MS/MS capabilities, but there are also other instrumental methods that allow obtaining structural 
information. One such method is ion mobility mass spectrometry [87] [Intermolecular 
Interactions in Biomolecular Systems Examined by Mass Spectrometry, Thomas Wyttenbach, 
Michael T. Bowers, Annual Review of Physical Chemistry, Vol. 58: 511-533 (Volume 
publication date May 2007)]. In the ion mobility spectrometer, ions (for example produced by an 
electrospray source) are pulsed in a chamber filled with helium gas and where an electric field is 
applied. The time the ions of a given mass and charge take to travel through the mobility chamber 
is proportional to the collision cross section of the ions. Ions having more open conformations 
travel slower than those having more compact conformations.  
When the electric field, gas pressure and gas temperature are well controlled, collision cross 
sections can be determined experimentally, and compared with cross sections calculated for 
plausible structural models. Bowers and co-workers studied several DNA higher-order structures 
(duplexes [88-90], triplexes [26], G-quadruplexes [35; 90-92]). and quadruplex-ligand 
noncovalent complexes [35; 93]. They demonstrated that double-helices were conserved in the 
gas phase for duplexes containing > 10 base pairs [89], that GC base pairs are more stable than 
AT base pairs [90], that the conformation of intramolecular G-quadruplexes is the same in the gas 
phase as in the sprayed solution [35; 92], and that the G-quadruplex ligands were bound via 
stacking on the tetrads. The ion mobility experiments were crucial for demonstrating that the 
structure of ions in the gas phase was indeed preserved from the solution after electrospray, and 
hence that gas-phase methods provide meaningful information for biologically relevant systems. 
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6.3 The future: spectroscopy of ions inside the mass spectrometer? 
A few groups have also developed instrumentation to detect the fluorescence of trapped ions [94-
96]. Using FRET probes, Parks and co-workers were able to probe the partial unfolding of a 
double-stranded DNA in the gas phase [97; 98]. Action spectroscopy (detecting mass spectral 
fragments) is more easily implemented on commercial mass spectrometers than fluorescence 
spectroscopy (detecting outgoing photons). Infrared or UV-visible spectra can be recorded by 
monitoring the fragmentation efficiency as a function of the wavelength. The potential of infrared 
spectroscopy, that has already proven useful to determine the conformation of small peptides in 
the gas phase [99; 100], for DNA structural analysis is currently under investigation [101], and 
the feasibility of recording UV-visible spectra of large DNA [81; 102] and DNA-ligand 
complexes [102] was demonstrated recently. In the future, spectroscopy of noncovalent 
complexes with selected stoichiometries (using the mass spectrometer) and conformations (using 
ion mobility chambers), might therefore become a new approach for probing structure of the 
complexes. 
7. Conclusions 
In the last paragraphs we tried to show what mass spectrometry could bring in the future for 
structural analysis of noncovalent complexes, but let us now summarize what mass spectrometry 
can do for characterizing ligand-nucleic acid complexes in present time. First, by definition ESI-
MS outperforms all other spectrophotometric techniques for the determination of the 
stoichiometry of noncovalent complexes. ESI-MS can be used to screen ligand for particular 
targets, to determine ligand selectivity among several possible targets, and even to determine 
equilibrium binding constants. Its rapidity, low sample consumption, and possibilities of 
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automation make ESI-MS a method of choice in the arsenal for studying ligand-nucleic acid 
interactions.   
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